FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Dexus to See Limited Balance Sheet Impact From Court Ruling on Melbourne Airport, Citigroup Says

By

Dexus (ASX:DXS) will see only a limited direct impact to its balance sheet from a New South Wales Supreme Court ruling that triggers a compulsory sale process for its stake in Melbourne Airport at market value, Citigroup said in a note, the Australian Financial Review reported Monday.

The court on Friday ruled that the company was in violation of confidentiality agreements and must dispose of the interest. Dexus holds a roughly 27.3% stake in Australia Pacific Airports, which owns Melbourne's Tullamarine airport and the Launceston airport in Tasmania.

Citi analyst Penny Howard said the investment is housed within Dexus' funds management platform and is excluded from net tangible asset calculations, which mitigates the balance sheet impact, according to the report.

"While near-term sentiment is likely to remain negative, a final resolution of the APAC matter - whether through appeal or a negotiated outcome - would represent a meaningful step forward for investors seeking a recovery and sustainable earnings growth trajectory in the medium term," AFR quoted Howard as saying.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Glenmark Pharmaceuticals' Profit Soars in Fiscal Q4

Glenmark Pharmaceuticals (NSE:GLENMARK, BOM:532296) posted a consolidated profit attributable to owners of 3.01 billion Indian rupees in the fiscal fourth quarter, up from 46.5 million rupees a year earlier, according to a Friday filing by the pharmaceutical manufacturer.Earnings per share for the quarter ended March 31 increased to 10.68 rupees from 0.16 rupees a year earlier.Revenue from operations rose to 37.7 billion rupees from 32.6 billion rupees in the prior-year period.

$BOM:532296$NSE:GLENMARK
Asia

Austco Healthcare Sees Fiscal Year 2026 Revenue Up to AU$95 Million, Shares Hit Over One-Year Low

Austco Healthcare (ASX:AHC) expects fiscal year 2026 revenue in the range of AU$90 million to AU$95 million, up 11% to 17% on fiscal year 2025 revenue of AU$81.4 million, according to a Monday Australian bourse filing.The company sees earnings before interest, taxes, depreciation, and amortization (EBITDA) in the range of AU$14 million to AU$14.6 million, up 7% to 12%, and EBITDA margin up almost 16%.The company said it has continued sales momentum across all regions, underpinned by new contract wins in New Zealand, Australia, Canada, and the US.The company's shares fell 18% in recent Monday trade, their lowest since late 2024.

$ASX:AHC
Asia

Technology One Says Norges Bank Increases Stake, Shares Jump 5%

Technology One (ASX:TNE) said Norges Bank raised its voting power in the firm to 6.1% from 5.05% on May 28, according to a Monday Australian bourse filing.The bank now holds nearly 20 million ordinary securities of the firm.Its shares rose 5% in recent trading on Monday.

$ASX:TNE